Literature DB >> 15900488

The HLA-G genotype is associated with IL-10 levels in activated PBMCs.

Roberta Rizzo1, Thomas Vauvert F Hviid, Marina Stignani, Alessandra Balboni, Maria Teresa Grappa, Loredana Melchiorri, Olavio R Baricordi.   

Abstract

Human leukocyte antigen (HLA)-G is an MHC class Ib molecule that is expressed at the feto-maternal interface during pregnancy. However, recent results have also shown that it may have important functions as an immuno-modulatory factor in adult life. Differences in the pattern of alternative splicing and in the stability of HLA-G mRNA transcripts have been associated with HLA-G polymorphisms, especially a 14 bp deletion/insertion polymorphism in the 3' untranslated region of the HLA-G gene. We have investigated the secretion of HLA-G5/soluble HLA-G1 and interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated peripheral blood mononuclear lymphocytes (PBMCs) in relation to the HLA-G 14 bp genotype. No HLA-G5/sHLA-G1 could be detected in the non-activated control PBMC culture media, and there were no significant differences among the three HLA-G 14 bp genotypes regarding IL-10 concentrations. In LPS-activated PBMC cultures, no significant differences among the three HLA-G 14 bp genotypes regarding HLA-G5/sHLA-G1 concentrations were observed. However, this was in contrast to the IL-10 levels (P=0.0004, Kruskal-Wallis test). The +14/+14 bp PBMC samples expressed higher levels of IL-10 when compared to the -14/+14 bp genotype and the -14/-14 bp genotype. Interestingly, the IL-10 G/G polymorphism at position -1082 was more frequent in the +14/+14 bp genotype (P=0.024, chi2 test). These results support an autocrine loop between HLA-G5/sHLA-G1 and IL-10 expression in activated PBMCs, which may result in higher IL-10 levels in +14/+14 bp HLA-G genotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900488     DOI: 10.1007/s00251-005-0788-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  71 in total

1.  ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms.

Authors:  C Perrey; S J Turner; V Pravica; W M Howell; I V Hutchinson
Journal:  Transpl Immunol       Date:  1999-06       Impact factor: 1.708

2.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

Review 3.  Cytokines and immuno-endocrine factors in recurrent miscarriage.

Authors:  K J Lim; O A Odukoya; T C Li; I D Cooke
Journal:  Hum Reprod Update       Date:  1996 Nov-Dec       Impact factor: 15.610

4.  Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate.

Authors:  Shang-mian Yie; Hanna Balakier; Gelareh Motamedi; Clifford L Librach
Journal:  Fertil Steril       Date:  2005-01       Impact factor: 7.329

5.  An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes.

Authors:  M Kirszenbaum; P Moreau; E Gluckman; J Dausset; E Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia.

Authors:  B K Rinehart; D A Terrone; S Lagoo-Deenadayalan; W H Barber; E A Hale; J N Martin; W A Bennett
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

7.  HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.

Authors:  K Kapasi; S E Albert; S Yie; N Zavazava; C L Librach
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

8.  Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10.

Authors:  S George; X Z Ruan; C Navarrete; D Turner; M Reynard; P Sweny; G Hamilton; D C Wheeler; S H Powis; J F Moorhead; Z Varghese
Journal:  Tissue Antigens       Date:  2004-05

9.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

Authors:  T Fujii; A Ishitani; D E Geraghty
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.

Authors:  C Münz; N Holmes; A King; Y W Loke; M Colonna; H Schild; H G Rammensee
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more
  18 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.

Authors:  L Donaghy; F Gros; L Amiot; C Mary; A Maillard; C Guiguen; J-P Gangneux
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment.

Authors:  Olavio R Baricordi; Marcello Govoni; Roberta Rizzo; Francesco Trotta
Journal:  Ann Rheum Dis       Date:  2007-08       Impact factor: 19.103

4.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

5.  Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: a meta-analysis of non-family-based studies.

Authors:  Wei Fan; Shangwei Li; Zhongying Huang; Qiong Chen
Journal:  J Assist Reprod Genet       Date:  2013-12-19       Impact factor: 3.412

Review 6.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

7.  Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells.

Authors:  Daria Bortolotti; Joel LeMaoult; Claudio Trapella; Dario Di Luca; Edgardo D Carosella; Roberta Rizzo
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

8.  Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.

Authors:  Tao Li; Haohai Huang; Dan Liao; Huahuang Ling; Bingguang Su; Maode Cai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

Review 9.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

10.  HLA-G expression levels influence the tolerogenic activity of human DC-10.

Authors:  Giada Amodio; Michela Comi; Daniela Tomasoni; Monica Emma Gianolini; Roberta Rizzo; Joël LeMaoult; Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Haematologica       Date:  2015-02-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.